SCHEMBL280034

SCHEMBL280034

CN1c2ccccc2C(c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.47
GAA P10253 3/20 0.47
MCL1 Q07820 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PAX8 Q06710 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 7/20 0.41
KDM4E B2RXH2 5/20 0.41
HTT P42858 4/20 0.41
HCRTR1 O43613 1/20 0.41
MAOA P21397 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
THRB P10828 3/20 0.39
RECQL P46063 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
CNR1 P21554 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30585081 1.00 LMNA (0.47) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL12723317 0.92 LMNA (0.41) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL14691262 0.88 LMNA (0.38) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL20383381 0.88 LMNA (0.38) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL19001736 0.85 PGR (0.37) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL22695432 0.82 HTT (0.40) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL23372033 0.81 HTT (0.39) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL22115458 0.81 LMNA (0.39) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL23557728 0.81 MEN1 (0.39) LMNAGAAMCL1ALDH1A1PAX8
SCHEMBL14691120 0.81 LMNA (0.55) LMNAGAAMCL1ALDH1A1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048238-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-23 US disclosed
US-20240244952-A1 ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) 2024-07-18 US disclosed
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) 2024-07-18 US disclosed
US-11912729-B2 Compound, display panel and display apparatus WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2024-02-27 US disclosed
US-20240023361-A1 LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDUING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-18 US disclosed
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS UDC IRELAND LIMITED (IE) 2023-12-05 US disclosed
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS UDC IRELAND LIMITED (IE) 2023-12-05 US disclosed
EP-3935129-B1 LIGANDS FOR NANO-SIZED MATERIALS MERCK PATENT GMBH (DE) 2023-11-29 EP disclosed
US-20230380262-A1 LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-23 US disclosed
WO-2011073149-A1 METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS BASF SE (DE) 2011-06-23 WO disclosed
WO-2011051404-A1 HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2011-05-05 WO disclosed
EP-2306541-A1 Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods Fujifilm Corporation (JP) 2011-04-06 EP disclosed
US-20110063485-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS FUJIFILM CORPORATION (JP) 2011-03-17 US disclosed
US-20110063485-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS FUJIFILM CORPORATION (JP) 2011-03-17 US disclosed
WO-2010079051-A1 SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2010-07-15 WO disclosed
US-7732061-B2 A layer of a mixture of metal oxide and a 1,3,5-tris(N-heterocycl-N-yl)-s-triazine between the electrodes; prevention of an increase in thedriving voltage if film thickens; charge transfer compounds; luminescence; pixel displays with images of favorable reproducible color SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-08 US disclosed
US-7732061-B2 A layer of a mixture of metal oxide and a 1,3,5-tris(N-heterocycl-N-yl)-s-triazine between the electrodes; prevention of an increase in thedriving voltage if film thickens; charge transfer compounds; luminescence; pixel displays with images of favorable reproducible color SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-08 US disclosed
US-20070194692-A1 Light emitting element and light emitting device having the light emittig element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-08-23 US disclosed
US-20070194692-A1 Light emitting element and light emitting device having the light emittig element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239754-A1 PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF PAH, HTR3D, CYP3A4 LMNA 1921/4885GAA 2928/4885MCL1 3000/4885
US-20240244952-A1 ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND LEF1, OCIAD1, OXA1L LMNA 3213/4885GAA 3583/4885MCL1 1699/4885
US-12048238-B2 Organometallic compound and organic light-emitting device including the same TRPC1, PPOX, LAGE3 LMNA 3314/4885GAA 3373/4885MCL1 2274/4885
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS OCIAD1, OCIAD2, DRD2 LMNA 4216/4885GAA 3782/4885MCL1 4028/4885
US-20110063485-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS PPOX, CRY1, FTO LMNA 1633/4885GAA 3951/4885MCL1 4269/4885
US-11912729-B2 Compound, display panel and display apparatus SAV1, TRPA1, C1S LMNA 2079/4885GAA 4657/4885MCL1 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.